Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 57(1): 43-47, 2023 Jan 06.
Article in Chinese | MEDLINE | ID: covidwho-2241864

ABSTRACT

This study collected epidemic data of COVID-19 in Zhengzhou from January 1 to January 20 in 2022. The epidemiological characteristics of the local epidemic in Zhengzhou High-tech Zone caused by the SARS-CoV-2 Delta variant were analyzed through epidemiological survey and big data analysis, which could provide a scientific basis for the prevention and control of the Delta variant. In detail, a total of 276 close contacts and 599 secondary close contacts were found in this study. The attack rate of close contacts and secondary close contacts was 5.43% (15/276) and 0.17% (1/599), respectively. There were 10 confirmed cases associated with the chain of transmission. Among them, the attack rates in close contacts of the first, second, third, fourth and fifth generation cases were 20.00% (5/25), 17.86% (5/28), 0.72% (1/139) and 14.81% (4/27), 0 (0/57), respectively. The attack rates in close contacts after sharing rooms/beds, having meals, having neighbor contacts, sharing vehicles with the patients, having same space contacts, and having work contacts were 26.67%, 9.10%, 8.33%, 4.55%, 1.43%, and 0 respectively. Collectively, the local epidemic situation in Zhengzhou High-tech Zone has an obvious family cluster. Prevention and control work should focus on decreasing family clusters of cases and community transmission.


Subject(s)
COVID-19 , Epidemics , Humans , SARS-CoV-2 , Incidence
2.
Pharmacoepidemiology and Drug Safety ; 31:611-612, 2022.
Article in English | Web of Science | ID: covidwho-2084087
3.
Pharmacoepidemiology and Drug Safety ; 31:614-614, 2022.
Article in English | Web of Science | ID: covidwho-2083876
5.
Pharmacoepidemiology and Drug Safety ; 31:608-608, 2022.
Article in English | Web of Science | ID: covidwho-2083821
6.
Pharmacoepidemiology and Drug Safety ; 31:622-622, 2022.
Article in English | Web of Science | ID: covidwho-2083578
7.
Acm Transactions on Intelligent Systems and Technology ; 13(2):23, 2022.
Article in English | Web of Science | ID: covidwho-1816793

ABSTRACT

Estimating human mobility responses to the large-scale spreading of the COVID-19 pandemic is crucial, since its significance guides policymakers to give Non-pharmaceutical Interventions, such as closure or reopening of businesses. It is challenging to model due to complex social contexts and limited training data. Recently, we proposed a conditional generative adversarial network (COVID-GAN) to estimate human mobility response under a set of social and policy conditions integrated from multiple data sources. Although COVID-GAN achieves a good average estimation accuracy under real-world conditions, it produces higher errors in certain regions due to the presence of spatial heterogeneity and outliers. To address these issues, in this article, we extend our prior work by introducing a new spatio-temporal deep generative model, namely, COVID-GAN+. COVID-GAN+ deals with the spatial heterogeneity issue by introducing a new spatial feature layer that utilizes the local Moran statistic to model the spatial heterogeneity strength in the data. In addition, we redesign the training objective to learn the estimated mobility changes from historical average levels to mitigate the effects of spatial outliers. We perform comprehensive evaluations using urban mobility data derived from cell phone records and census data. Results show that COVID-GAN+ can better approximate real-world human mobility responses than prior methods, including COVID-GAN.

8.
21st IEEE International Conference on Data Mining (IEEE ICDM) ; : 767-776, 2021.
Article in English | Web of Science | ID: covidwho-1806911

ABSTRACT

Spatial data are ubiquitous, massively collected, and widely used to support critical decision-making in many societal domains, including public health (e.g., COVID-19 pandemic control), agricultural crop monitoring, transportation, etc. While recent advances in machine learning and deep learning offer new promising ways to mine such rich datasets (e.g., satellite imagery, COVID statistics), spatial heterogeneity - an intrinsic characteristic embedded in spatial data - poses a major challenge as data distributions or generative processes often vary across space at different scales, with their spatial extents unknown. Recent studies (e.g., SVANN, spatial ensemble) targeting this difficult problem either require a known space-partitioning as the input, or can only support very limited number of partitions or classes (e.g., two) due to the decrease in training data size and the complexity of analysis. To address these limitations, we propose a model-agnostic framework to automatically transform a deep learning model into a spatial-heterogeneity-aware architecture, where the learning of arbitrary space partitionings is guided by a learning-engaged generalization of multivariate scan statistic and parameters are shared based on spatial relationships. We also propose a spatial moderator to generalize learned space partitionings to new test regions. Experiment results on real-world datasets show that the spatial transformation and moderation framework can effectively capture flexibly-shaped heterogeneous footprints and substantially improve prediction performances.

9.
Eur Rev Med Pharmacol Sci ; 24(23): 12589-12592, 2020 12.
Article in English | MEDLINE | ID: covidwho-995020

ABSTRACT

OBJECTIVE: The current pandemic makes the international flights facing multiple challenges including infection during flights. Here the objective is to analyze the infection trend of flights from a regional data set and discuss the solutions for diagnosis and travel medicine. MATERIALS AND METHODS: The public data was applied for trend analysis and new solutions were provided based on the current diagnosis information and resembling cancer diagnosis. RESULTS: Flights infection has decreased since the large-scale cease of flights. Challenges of prevention of SARS-CoV-2 infection in flights exist due to testing accuracy, asymptomatic and many other factors including people gathering. To avoid the pandemic worsen, the solutions are provided for new coming flight resumes. Hotel, mandatory PPE, airport diagnosis, rapid imaging/biomarker diagnosis by advanced high-technology and emergency-travel medicine department are suggested as solutions. CONCLUSIONS: SARS-CoV-2 prevention in flights needs multiple solutions by potential on-site diagnosis and urgent establishment of a travel medicine unit at airport.


Subject(s)
Airports , COVID-19 Nucleic Acid Testing , COVID-19/prevention & control , Disinfection , Personal Protective Equipment , Physical Distancing , Quarantine , Aerospace Medicine , Aircraft , Asymptomatic Infections , Aviation , Biosensing Techniques , COVID-19/diagnosis , COVID-19/transmission , Carrier State , Environment Design , Humans , Neoplasms/diagnosis , SARS-CoV-2 , Travel Medicine
SELECTION OF CITATIONS
SEARCH DETAIL